Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients: Brief Communication

Nephrology

Volumn 15, Issue 1, 2010, Pages 23-26

  Bolignano, Davide ^a   Coppolino, Giuseppe ^a,b   Romeo, Adolfo ^a   Lacquaniti, Antonio ^a   Buemi, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

Dialysis adequacy; Haemodialysis; Inflammation; Neutrophil gelatinase associated lipocalin

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LABORATORY TEST; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ACUTE-PHASE PROTEINS; FEMALE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; PILOT PROJECTS; PROTO-ONCOGENE PROTEINS; RENAL DIALYSIS;

EID: 77149148114     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01163.x     Document Type: Article

References (16)

1. Bolignano D, Donato V, Coppolino G et al. Neutrophil gelatinase- associated lipocalin (NGAL) as a marker of kidney damage. Am. J. Kidney Dis. 2008 52 : 595 605.
2. Bolignano D, Coppolino G, Campo S et al. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am. J. Nephrol. 2007 27 : 373 378.
3. Bolignano D, Coppolino G, Lacquaniti A, Nicocia G, Buemi M. Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function. Kidney Blood Press. Res. 2008 31 : 274 279.
4. Bolignano D, Lacquaniti A, Coppolino G et al. Gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press. Res. 2009 32 : 91 8.
5. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2009 4 : 337 344.
6. Kuwabara T, Mori K, Mukoyama M et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009 75 : 285 294.
7. Bolignano D, Coppolino G, Aloisi C, Romeo A, Nicocia G, Buemi M. Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function. J. Investig. Med. 2008 56 : 997 1003.
8. Kusaka M, Kuroyanagi Y, Mori T et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant. 2008 17 : 129 134.
9. Kato S, Chmielewski M, Honda H et al. Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 2008 3 : 1526 1533.
10. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim. Biophys. Acta 2000 1482 : 298 307.
11. Merino A, Nogueras S, Buendía P et al. Microinflammation and endothelial damage in hemodialysis. Contrib. Nephrol. 2008 161 : 83 8.
12. Filiopoulos V, Hadjiyannakos D, Metaxaki P et al. Inflammation and oxidative stress in patients on hemodiafiltration. Am. J. Nephrol. 2008 28 : 949 957.
13. Roudkenar MH, Kuwahara Y, Baba T et al. Oxidative stress induced lipocalin 2 gene expression: Addressing its expression under the harmful conditions. J. Radiat. Res. 2007 48 : 39 44.
14. Jonsson P, Stahl ML, Ohlsson K. Extracorporeal circulation causes release of neutrophil gelatinase-associated lipocalin (NGAL). Mediators Inflamm. 1999 8 : 169 171.
15. Hörl WH. Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules. J. Am. Soc. Nephrol. 2002 13 (Suppl 1 S62 71.
16. Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil- gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005 579 : 773 777.